naa a22 4500 510779220 CHVBK 20180411083241.0 cr unu---uuuuu 180411e20130201xx s 000 0 eng 10.1007/s11892-012-0339-7 doi (NATIONALLICENCE)springer-10.1007/s11892-012-0339-7 Management of Hyperglycemia in Hospitalized Patients with Renal Insufficiency or Steroid-Induced Diabetes [Elektronische Daten] [David Baldwin, Jill Apel] Pharmacologic doses of glucocorticoids and chronic renal failure are challenging comorbidities and complications for safe and effective dosing of insulin for the management of hospitalized patients with diabetes. Glucocorticoids are used widely in hospitalized patients and will commonly provoke new-onset hyperglycemia in patients without a prior history of diabetes or will provoke severely uncontrolled hyperglycemia in patients with known diabetes. Insulin therapy is invariably necessary for the treatment of glucocorticoid-induced hyperglycemia and must be tailored to the pharmacodynamics of the glucocorticoid being given. Renal failure causes a decrease in the clearance of insulin, especially exogenous injected insulin. Dosing algorithms for hospitalized patients should be adjusted for patients with renal failure in order to minimize hypoglycemia. Many patients with type 2 diabetes will need little or no therapy after the development of end-stage renal failure. Care must be taken to avoid the overtreatment of hyperglycemia. Springer Science+Business Media New York, 2012 Inpatient diabetes nationallicence Hospitalized diabetes nationallicence Steroid induced diabetes nationallicence Glucocorticoid induced diabetes nationallicence Chronic renal failure nationallicence End-stage renal failure nationallicence Glycemic control nationallicence Insulin glargine nationallicence Hypoglycemia nationallicence Renal insufficiency nationallicence Baldwin David Section of Endocrinology, Rush University Medical Center, 1725 W. Harrison St. suite 250, 60612, Chicago, IL, USA aut Apel Jill Section of Endocrinology, Rush University Medical Center, 1725 W. Harrison St. suite 250, 60612, Chicago, IL, USA aut Current Diabetes Reports Current Science Inc. 13/1(2013-02-01), 114-120 1534-4827 13:1<114 2013 13 11892 https://doi.org/10.1007/s11892-012-0339-7 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11892-012-0339-7 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Baldwin David Section of Endocrinology, Rush University Medical Center, 1725 W. Harrison St. suite 250, 60612, Chicago, IL, USA aut NATIONALLICENCE 700 1- Apel Jill Section of Endocrinology, Rush University Medical Center, 1725 W. Harrison St. suite 250, 60612, Chicago, IL, USA aut NATIONALLICENCE 773 0- Current Diabetes Reports Current Science Inc 13/1(2013-02-01), 114-120 1534-4827 13:1<114 2013 13 11892 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer